Abstract
Pirh2 is a Ring-H2 domain containing E3 ubiquitin ligase that targets several important tumor suppressor genes for proteasomal degradation. Overexpression of Pirh2 is frequently detected in many clinical tumor tissues including hepatocellular carcinoma (HCC). However, the molecular mechanism of Pirh2 activation in tumorigenesis still remains poorly understood. In this study, we find a Pirh2-binding protein, SCYL1 binding protein 1 (SCYL1BP1), that can promote the ubiquitin-dependent degradation of Pirh2. SCYL1BP1 colocalized with Pirh2 in the cytoplasm and prevented its localization to the nucleus. Ectopic expression of SCYL1BP1 increased the expression of p53 and further inhibited the G(1)/S transition of HCC cell lines. Conversely, knock down of SCYL1BP1 restored the expression of Pirh2 and inhibited p53 at protein level. Functional assays found that reintroduction of SCYL1BP1 into HCC cell lines significantly inhibited cell proliferation, foci formation, colony formation in soft agar and tumor formation in nude mice, suggesting the strong tumor-suppressive function of SCYL1BP1 in HCC progression. Furthermore, SCYL1BP1 was found to be frequently downregulated in HCC clinical specimens compared to their paired non-tumor tissue...Continue Reading
References
Jun 26, 1992·Cell·J MomandA J Levine
Feb 1, 1991·Genes & Development·J MartinezA J Levine
Jul 15, 1994·Cell·K PolyakJ Massagué
Aug 30, 2002·Journal of Molecular Endocrinology·L K BeitelM A Trifiro
Nov 19, 2002·Cancer·Yi WangXin-Yuan Guan
Mar 26, 2003·Cell·Roger P LengSamuel Benchimol
Aug 29, 2003·Molecular and Cellular Biology·Kevin O'KeefeYanping Zhang
Jan 1, 2004·The Journal of Biological Chemistry·Ian R LoganCraig N Robson
Nov 18, 2004·Journal of the National Cancer Institute·Wenrui DuanMiguel A Villalona-Calero
Mar 23, 2005·Biochemical and Biophysical Research Communications·Liping ZhangKeke Huo
Sep 6, 2005·Journal of Virology·Mingzhou ChenDenis Gerlier
Feb 4, 2006·Molecular Cell·Christopher L Brooks, Wei Gu
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Skye H ChengAndrew T Huang
Jun 15, 2007·The EMBO Journal·Shanshan DuanMian Wu
Oct 24, 2007·Biochemical and Biophysical Research Communications·Gang ZhengYu-Chung Yang
Nov 17, 2007·Cancer Research·Li FuXin-Yuan Guan
Nov 17, 2007·Cancer Research·Takayuki HattoriMasatoshi Kitagawa
Nov 21, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ning-Fang MaXin-Yuan Guan
Mar 4, 2008·Seminars in Radiation Oncology·Dimitry S A Nuyten, Marc J van de Vijver
May 15, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Leilei ChenXin-Yuan Guan
May 16, 2009·Cancer Science·Mai ShimadaMasatoshi Kitagawa
Jun 25, 2009·Cancer·Xiao-Min WangFan Wu
Sep 5, 2009·Nature Cell Biology·Qinxi LiSheng-Cai Lin
Mar 26, 2010·The Journal of Clinical Investigation·Leilei ChenXin-Yuan Guan
Jul 6, 2010·FEBS Letters·Jing YanKeke Huo
Sep 21, 2010·FEBS Letters·Jing YanKeke Huo
Jan 18, 2011·Human Pathology·Xiaodong HuangAiguo Shen
Citations
Mar 12, 2016·The Journal of Investigative Dermatology·Ying LiuJiang Chen
Jun 12, 2014·Protein & Cell·Ming LiuXin-Yuan Guan
Nov 1, 2016·Molecular Neurobiology·Weidong ZhangAiguo Shen
Sep 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Zhi-Ping YangWan-Xin Wu
Mar 31, 2015·Diabetologia·Danfeng PengWeiping Jia
Mar 26, 2015·Frontiers in Genetics·Kerstin BrinkmannHamid Kashkar
Oct 27, 2015·PloS One·Laure BridouxRené Rezsohazy
May 17, 2013·Molecular Medicine Reports·Lei LiuYi Hou
Feb 19, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ying LiuJiang Chen
Jan 13, 2015·Oncotarget·Jian WangXin-Yuan Guan
Jan 10, 2021·Biochemical Pharmacology·Zhifei XuPeihua Luo